Advertisement

Topics

ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

16:01 EDT 13 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
ArQule, Inc. (Nasdaq: ARQL) today announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,650...

Other Sources for this Article

Corporate Contact:
ArQule, Inc.
Marc Schegerin, M.D., 781-994-0440
Senior Vice President, Strategy, Communication, and Finance
marc@arqule.com
or
Media Contact:
LifeSci Public Relations
Allison Blum, Ph.D., 646-627-8383
Allison@lifescipublicrelations.com

NEXT ARTICLE

More From BioPortfolio on "ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...